Compugen (CGEN) EBT Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 3,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,916.00 |
| Dec 31, 2025 | 49,999.00 |
| Sep 30, 2025 | -40,069.00 |
| Jun 30, 2025 | -147,479.00 |
| Mar 31, 2025 | 2,919.00 |
| Dec 31, 2024 | -47,151.00 |
| Dec 31, 2023 | 9,640.00 |
| Dec 31, 2016 | -1.60 Mn |
| Sep 30, 2016 | -817,161.00 |
| Jun 30, 2016 | 171,985.00 |
| Mar 31, 2016 | -834,124.00 |
| Dec 31, 2015 | 1,705.00 |
| Sep 30, 2015 | -263,008.00 |
| Jun 30, 2015 | -293,789.00 |
| Mar 31, 2015 | -110,848.00 |
| Dec 31, 2014 | 12,748.00 |
| Sep 30, 2014 | -2,554.00 |
| Jun 30, 2014 | 1.37 Mn |
| Mar 31, 2014 | 199,373.00 |
| Dec 31, 2013 | 386,418.00 |
| Sep 30, 2013 | 296,151.00 |
| Dec 31, 2010 | 659,347.00 |